Alterity Therapeutics analyst ratings
Alterity Therapeutics analyst ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
06/23/2022 | 377.25% | Goldman Sachs | $11 → $3 | Maintains | Neutral |
08/20/2021 | 536.33% | Benchmark | → $4 | Initiates Coverage On | → Speculative Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
06/23/2022 | 377.25% | 高盛 | 11 美元 → 3 美元 | 維護 | 中立 |
2021 年 8 月 20 日 | 536.33% | 基準 | → 4 美元 | 啓動覆蓋範圍開啓 | → 投機性買入 |
Alterity Therapeutics Questions & Answers
Alterity Therapeutics 問題與解答
The latest price target for Alterity Therapeutics (NASDAQ: ATHE) was reported by Goldman Sachs on June 23, 2022. The analyst firm set a price target for $3.00 expecting ATHE to rise to within 12 months (a possible 377.25% upside). 2 analyst firms have reported ratings in the last year.
高盛於2022年6月23日公佈了Alterity Therapeutics(納斯達克股票代碼:ATHE)的最新目標股價。該分析公司將目標股價定爲3.00美元,預計ATHE將在12個月內升至12個月內(可能上漲377.25%)。去年有兩家分析公司公佈了評級。
The latest analyst rating for Alterity Therapeutics (NASDAQ: ATHE) was provided by Goldman Sachs, and Alterity Therapeutics maintained their neutral rating.
Alterity Therapeutics(納斯達克股票代碼:ATHE)的最新分析師評級由高盛提供,Alterity Therapeutics維持中性評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alterity Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alterity Therapeutics was filed on June 23, 2022 so you should expect the next rating to be made available sometime around June 23, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Alterity Therapeutics的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。Alterity Therapeutics的最新評級是在2022年6月23日公佈的,因此您應該預計下一個評級將在2023年6月23日左右公佈。
While ratings are subjective and will change, the latest Alterity Therapeutics (ATHE) rating was a maintained with a price target of $11.00 to $3.00. The current price Alterity Therapeutics (ATHE) is trading at is $0.63, which is out of the analyst's predicted range.
儘管評級是主觀的,而且會發生變化,但最新的Alterity Therapeutics(ATHE)評級維持不變,目標股價爲11.00美元至3.00美元。Alterity Therapeutics(ATHE)目前的交易價格爲0.63美元,超出了分析師的預期區間。